West Pharmaceutical Services Inc (NYSE:WST), a manufacturer of containment and delivery solutions for injectable medicines, announced on Tuesday that its board of directors has declared a regular quarterly dividend of USD0.22 per share on the company's common stock.
This amount is unchanged from the previous quarterly dividend.
The dividend is payable on 5 August 2026 to shareholders of record as of 29 July 2026.
Alvotech and Lotus agree licensing deal for two biosimilar candidates
Quest Diagnostics declares quarterly dividend of of USD0.86 per share
BSF secures exclusive global commercialisation partnership for ETSYL
Saniona grants AstronauTx worldwide rights to neurological disease programme
Ridgetech reports financial results for fiscal year to March 2026
AMGEN announces Q3 2026 dividend
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones